跳至主要内容
临床试验/NCT06646107
NCT06646107招募中不适用

Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There a Difference

Attikon Hospital1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2025年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
240
试验地点
1
主要终点
Changes in Hba1c

研究概览

简要总结

In this observaltional study, 240 patients aged >12 years old with T1DM who are on multiple daily injections or insulin pump and are scheduled to start using MiniMed 780G system will be included.We aim to compare patients' adherence to Mediterranean diet (MD) before and 12 weeks after initiation of MiniMed 780G and its association with CGM and insulin metrics, as well as anthropometric measurements, BMI, body composition, lipid levels, blood pressure and gut microbioma. Moreover, at baseline, at six and 12 months, markers of endothelial and cardiovascular function will be also assessed and associated with the use of Minimed 780G and the adherence to MD.

详细描述

This observational study will include 240 participants (80 participants per country) from IGI region (Italy, Greece and Israel), children adolescents and young adults (12> years old) with T1D that are on multiple daily injections or insulin pump and are scheduled to start using MiniMed 780G system. After a 7-day run-in period, participants will be evaluated with food intake log and adherence to Meditteranean Diet (MD) with PREDIMED questionnaire. One hour session on MD and healthy impact on Diabetes will be provided to all participants and will be assigned to initiate MiniMed 780G and followed for 12 weeks. HbA1c, CGM and Insulin Metrics, anthropometric measurements, body composition, blood pressure and lipid leves as well a gut microbioma will be performed at baseline and 12 weeks, after MiniMed 780G initiation. A 7-day food diary logbook will be collected to identify the amount and type of the food at baseline and at the end of the study. At baseline, at 6 and at 12 months, markers of endothelial and cardiovascular function will also be assessed. An extension phase will include additional 3 and 6, which concludes one year of follow-up.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
12 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of type 1 diabetes >1 year prior to consent date. Diagnosis of type 1 diabetes is based on the investigator's judgment; C peptide level and antibody determinations are not required.
  • HbA1c < 12.5%
  • Age >7years at the initiation of the system
  • Multiple Daily Injections (Basal Bolus therapy) with Total daily insulin use of great than 8.0 units per day over a 1-week period
  • Clinically able to start the AHCL system
  • History of 3 clinic visits in the last year

排除标准

  • 1. Diabetic Ketoacidosis in the 6 months prior to screening visits

结局指标

主要结局

Changes in Hba1c

时间窗: Baseline, 3 months

Differences in HbA1c at baseline and 3 months after the initiation of MiniMed 780G

Changes in TIR

时间窗: Baseline, 3 months

Changes in TIR at baseline and 3 months after the initiation of MiniMed 780G

Changes in TBR

时间窗: Baseline, 3 months

Changes in TBR at baseline and 3 months after the initiation of MiniMed 780G

Changes in TAR

时间窗: Baseline, 3 months

Changes in TAR at baseline and 3 months after the initiaton of MiniMed 780G

Changes in bolus doses

时间窗: Baseline, 3 months

Changes in bolus dosed at baseline and 3 months after the initiation of MiniMed 780G

Changes in basal doses

时间窗: Baseline, 3 months

Changes in basal doses at baseline and 3 months after the initiation of MiniMed 780G

Changes in autocorrection doses

时间窗: Baseline, 3 months

Changes in autocorrection doses between baseline and 3 months after the initiation of MiniMed 780G:

次要结局

  • Changes in pulse wave velocity(m/s)(Baseline, 6 months, 12 months)
  • Changes in endothelial glycocalyx thickness (μm)(Baseline, 6 months, 12 months)
  • Changes in global longidutinal strain (%)(Baseline, 6 months, 12 months)
  • Changes in CAP (dB/m)(Baseline, 6 months, 12 months)
  • Changes in gut microbioma(Baseline,3 months)
  • Changes in coronary flow reserve(Baseline, 6 months, 12 months)
  • Changes in central aortic blood pressure (mmHg)(Baseline, 6 months, 12 months)
  • Changes in Ε score (Kpa)(Baseline, 6 months, 12 months)

研究者

发起方
Attikon Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

VAIA LAMBADIARI

Professor of Internal Medicine-Endocrinology

Attikon Hospital

研究点 (1)

Loading locations...

相似试验